Publicaciones (21) Publicaciones en las que ha participado algún/a investigador/a

2013

  1. ACTH analogues medications for the treatment of crystal-induced acute inflammation: A target to be explored?

    Joint Bone Spine

  2. Automated radiofrequency-based US measurement of common carotid intima-media thickness in ra patients treated with synthetic vs synthetic and biologic DMARDS

    Rheumatology (United Kingdom), Vol. 52, Núm. 2, pp. 376-381

  3. Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en el lupus eritematoso sistémico

    Reumatologia Clinica, Vol. 9, Núm. 5, pp. 281-296

  4. Diferente expresión clínica de los pacientes con espondilitis anquilosante según el sexo en función del tiempo de evolución. Datos de REGISPONSER

    Reumatologia Clinica, Vol. 9, Núm. 4, pp. 221-225

  5. Efficacy and safety of nonbiologic immunosuppressants in the treatment of nonrenal systemic lupus erythematosus: A systematic review

    Arthritis Care and Research, Vol. 65, Núm. 11, pp. 1775-1785

  6. Foreword: Gout

    Gout

  7. Gout

    Future Medicine Ltd., pp. 1-240

  8. Kaiser Permanent Pyramid In Patients With Gout: The Most Severe Gout Is Associated To The Most Complex Patients

    ARTHRITIS AND RHEUMATISM

  9. LIVER Outcomes In Gout Patients Treated With Febuxostat and Altered LIVER Function TESTS

    ARTHRITIS AND RHEUMATISM

  10. Leflunomide, a valid and safe drug for the treatment of chronic anterior uveitis associated with juvenile idiopathic arthritis

    Clinical Rheumatology, Vol. 32, Núm. 11, pp. 1673-1675

  11. Les analogues de l'ACTH dans le traitement de l'inflammation aiguë microcristalline, une cible à explorer?

    Revue du Rhumatisme (Edition Francaise)

  12. Low-Dose Anakinra Is Effective For The Prophylaxis Of Acute Episodes Of Inflammation In Severe Tophaceous Gout

    ARTHRITIS AND RHEUMATISM

  13. Lupus eritematoso sistémico (I)

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 11, Núm. 32, pp. 1955-1965

  14. Lupus eritematoso sistémico (I)

    Medicine (Spain), Vol. 11, Núm. 32, pp. 1955-1965

  15. Phagocyte dysfunction in polymyalgia rheumatica and other age-related, chronic, inflammatory conditions

    Journal of Leukocyte Biology, Vol. 94, Núm. 5, pp. 1071-1078

  16. Protocolo de seguimiento del tratamiento inmunosupresor en pacientes con enfermedades autoinmunes

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 11, Núm. 33, pp. 2056-2060

  17. Scoring with the berlin MRI method for assessment of spinal inflammatory activity in patients with ankylosing spondylitis: A calibration exercise among rheumatologists

    Clinical and Experimental Rheumatology, Vol. 31, Núm. 6, pp. 883-888

  18. Serum uric acid and metabolic risk

    Current Medical Research and Opinion, Vol. 29, Núm. SUPPL.3, pp. 9-15

  19. Treatment of autoinflammatory diseases: Results from the Eurofever Registry and a literature review

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 5, pp. 678-685

  20. Urate-lowering therapy: Uricases

    Gout (Future Medicine Ltd.), pp. 190-201